Hammer S, Schlicker A, Zitzmann-Kolbe S, Baumgart S, et al. Darolutamide potentiates the antitumor efficacy of a PSMA-targeted thorium-227 conjugate (PSMA-TTC) by a dual mode-of-action in prostate cancer models. Clin Cancer Res 2021 May 25. pii: 1078-0432.CCR-21-0342.
PMID: 34035067